Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2009 Apr 15;19(8):2154-7. doi: 10.1016/j.bmcl.2009.02.119. Epub 2009 Mar 4.

Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.

Author information

1
Department of Forest and Forest Products Science, Faculty of Agriculture, Kyushu University, Fukuoka, Japan.

Abstract

Prostate cancer is the most common cancer in men in Western countries, with a high incidence of bone metastasis. Ganoderic acid DM, with 5alpha-reductase inhibitory and androgen receptor (AR) binding activity, isolated from the ethanol extracts of Ganoderma lucidum, can inhibit prostate cancer cell growth and block osteoclastogenesis.

PMID:
19289282
DOI:
10.1016/j.bmcl.2009.02.119
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center